TITLE

Alteraciones del metabolismo óseo mineral en la enfermedad renal crónica del paciente trasplantado renal

AUTHOR(S)
Oliva, María Ovidia López; Caba, Domingo del Castillo; Plumed, Jaime Sánchez
PUB. DATE
February 2009
SOURCE
Nefrologia;Feb2009 Supplement, Vol. 29 Issue S1, p31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Description: Recently, the Foundation has proposed new definitions KDIGO to refer to the alterations of bone - mineral metabolism in patients with chronic renal disease (CRD), relegating the traditional term of renal osteodystrophy (ODR). Recommend: - The term ODR exclusively to define alterations in bone morphology and architecture characteristic of the ERC. - And the term of bone-mineral alteration associated with the CRD to describe biochemical changes, and skeletal calcifications that occur as a result of alterations in mineral metabolism in the CRD. Pathophysiology: The different metabolic abnormalities are secondary to the progressive loss of renal mass and renal function that leads to retention of phosphorus and a decrease in the levels of calcitriol which are responsible for the skeletal resistance to the action of PTH. Clinical features: The main clinical manifestations of abnormal bone mineral metabolism are posttransplantation osteoporosis and osteopenia producing an increase in fractures, osteonecrosis, and bone pain. Diagnostic methods: Biochemical parameters (calcium, phosphorus, PTH, 25 hydroxyvitamin D), X-ray bone densitometry and bone biopsy. (Evidence B) Therapeutic alternatives: It is recommended for the treatment and prevention of osteopenia - osteoporosis in transplant patients based on data from clinical evidence available from other study populations, such as in patients with chronic kidney disease. In addition to specific treatment, we must take into account the preventive measures to reduce the risk of fractures. Treatment includes specific measures for the prevention of bone loss (active metabolite of vitamin D analogues and bisphosphonates) and the treatment of persistent hyperparathyroidism (calcimiméticos). (Evidence B).
ACCESSION #
43979379

 

Related Articles

  • Advances in bone assessment. Gambacciani, Marco // Contemporary OB/GYN;Sep2003, Vol. 48 Issue 9, p73 

    Discusses medical advances in bone assessment. Information on osteoporosis; Relationship between bone mineral density and fracture risk; Role of quantitative ultrasound in bone assessment.

  • Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing’s syndrome. Fütő, L.; Tőke, J.; Patócs, A.; Szappanos, Á.; Varga, I.; Gláz, E.; Tulassay, Z.; Rácz, K.; Tóth, M. // Osteoporosis International;Jul2008, Vol. 19 Issue 7, p941 

    We examined bone densitometric data in a four-year follow-up period before and after the cure of CS. Plasma cortisol concentrations were similar, but the duration of estimated glucocorticoid excess was longer in patients with prevalent bone fractures compared to those without fractures. After...

  • Palangeal Quantitative Ultrasound, Phalangeal Morphometric Variables, and Vertebral Fracture Discrimination. Guglielmi, G.; Njeh, C.F.; Terlizzi, F.; Serio, D.A.; Scillitani, A.; Cammisa, M.; Fan, B.; Lu, Y.; Genant, H.K. // Calcified Tissue International;Apr2003, Vol. 72 Issue 4, p469 

    The aim of this study was to evaluate the association among phalangeal morphometric parameters, amplitude-dependent speed of sound (AD-SOS), ultrasound bone profile index (UBPI), and spinal bone mineral density (BMD) and fracture status. One hundred women (controls, mean age 53 ± 12 years)...

  • Association of PLXNA2 polymorphisms with vertebral fracture risk and bone mineral density in postmenopausal Korean population. Hwang, J.; Lee, J.; Park, B. L.; Kim, K.; Ryu, H.; Han, B.; Kim, J.; Oh, B.; Kimm, K.; Park, B.; Shin, H. D.; Kim, T. H.; Hong, J.; Park, E.; Kim, D.; Koh, J.; Kim, G.; Kim, S. // Osteoporosis International;Nov2006, Vol. 17 Issue 11, p1592 

    Plexin A2 ( PLXNA2) is a receptor that recognizes secreted or membrane-bound semaphorin 3A, which is implicated in neural regulation of bone metabolism. In the present study, we identified 48 genetic polymorphisms in PLXNA2 by resequencing, and 10 single nucleotide polymorphisms (SNPs) were...

  • Use of Bone Densitometry by Ontario Family Physicians. Ridout, R.; Hawker, G. A. // Osteoporosis International;May2000, Vol. 11 Issue 5, p393 

    : A stratified (urban/rural), computer-generated random sample of 797 Ontario members of the College of Family Physicians of Canada received a self-administered questionnaire by mail. The questionnaire examined current use of bone densitometry, focusing on reasons for its use, factors that limit...

  • Prediction of Osteoporotic Fractures by Bone Densitometry and COLIA1 Genotyping: A Prospective, Population-Based Study in Men and Women. McGuigan, F. E. A.; Armbrecht, G.; Smith, R.; Felsenberg, D.; Reid, D. M.; Ralston, S. H. // Osteoporosis International;Feb2001, Vol. 12 Issue 2, p91 

    : Osteoporosis is a common disease with a strong genetic component, characterized by reduced bone mineral density and increased fracture risk. Although the genetic basis of osteoporosis is incompletely understood, previous studies have identified a polymorphism affecting an Sp1 binding site in...

  • Improving osteoporosis management in patients with fractures. Johnson, S. I.; Petkov, V. I.; Williams, M. I.; Via, P. S.; Adler, Robert A. // Osteoporosis International;Sep2005, Vol. 16 Issue 9, p1079 

    A history of fracture is an independent risk factor for future fractures, but patients who have sustained a fracture are rarely evaluated for osteoporosis (OP). The objective of this study was to determine if a simple intervention in a general orthopedic clinic would lead to more fracture...

  • Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women. Leslie, W. D.; Metge, C.; Ward, L. // Osteoporosis International;Jun2003, Vol. 14 Issue 4, p334 

    Hip fractures are independently associated with advancing age, specific clinical risk factors (CRFs), and low bone mineral density (BMD). The use of BMD T-scores for quantifying fracture risk ignores the contribution of age and CRFs. We previously developed a mathematical model of absolute hip...

  • Use of Clinical Risk Factors in Elderly Women with Low Bone Mineral Density to Identify Women at Higher Risk of Hip Fracture: The EPIDOS Prospective Study. Dargent-Molina, P.; Douchin, M. N.; Cormier, C.; Meunier, P. J.; Bréart, G. // Osteoporosis International;Jul2002, Vol. 13 Issue 7, p593 

    : Elderly women with very low bone mineral density (BMD) (T-score ≤-3.5) have a risk of hip fracture more than two times higher than the average risk of women of the same age. Using data from the EPIDOS prospective study, we have shown that by measuring BMD on the 50% of women who have the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics